Bone Marrow Myeloid Cells Regulate Myeloid-Biased Hematopoietic Stem Cells via a Histamine-Dependent Feedback Loop.
Xiaowei Chen,Huan Deng,Michael J Churchill,Larry L Luchsinger,Xing Du,Timothy H Chu,Richard A Friedman,Moritz Middelhoff,Hongxu Ding,Yagnesh H Tailor,Alexander L E Wang,Haibo Liu,Zhengchuan Niu,Hongshan Wang,Zhengyu Jiang,Simon Renders,Siu-Hong Ho,Spandan V Shah,Pavel Tishchenko,Wenju Chang,Theresa C Swayne,Laura Munteanu,Andrea Califano,Ryota Takahashi,Karan K Nagar,Bernhard W Renz,Daniel L Worthley,C Benedikt Westphalen,Yoku Hayakawa,Samuel Asfaha,Florence Borot,Chyuan-Sheng Lin,Hans-Willem Snoeck,Siddhartha Mukherjee,Timothy C Wang
DOI: https://doi.org/10.1016/j.stem.2017.11.003
IF: 23.9
2017-01-01
Cell Stem Cell
Abstract:Myeloid-biased hematopoietic stem cells (MB-HSCs) play critical roles in recovery from injury, but little is known about how they are regulated within the bone marrow niche. Here we describe an auto-/paracrine physiologic circuit that controls quiescence of MB-HSCs and hematopoietic progenitors marked by histidine decarboxylase (Hdc). Committed Hdc+ myeloid cells lie in close anatomical proximity to MB-HSCs and produce histamine, which activates the H2 receptor on MB-HSCs to promote their quiescence and self-renewal. Depleting histamine-producing cells enforces cell cycle entry, induces loss of serial transplant capacity, and sensitizes animals to chemotherapeutic injury. Increasing demand for myeloid cells via lipopolysaccharide (LPS) treatment specifically recruits MB-HSCs and progenitors into the cell cycle; cycling MB-HSCs fail to revert into quiescence in the absence of histamine feedback, leading to their depletion, while an H2 agonist protects MB-HSCs from depletion after sepsis. Thus, histamine couples lineage-specific physiological demands to intrinsically primed MB-HSCs to enforce homeostasis.